- Home
- OMCC vs CRIS Comparison
OMCC vs CRIS Comparison
Compare OMCC & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMCC
- CRIS
- Stock Information
- Founded
- OMCC 1985
- CRIS 2000
- Country
- OMCC United States
- CRIS United States
- Employees
- OMCC N/A
- CRIS N/A
- Industry
- OMCC
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OMCC
- CRIS Health Care
- Exchange
- OMCC NYSE
- CRIS Nasdaq
- Market Cap
- OMCC 40.0M
- CRIS 32.8M
- IPO Year
- OMCC N/A
- CRIS 2000
- Fundamental
- Price
- OMCC $6.00
- CRIS $1.48
- Analyst Decision
- OMCC
- CRIS Strong Buy
- Analyst Count
- OMCC 0
- CRIS 3
- Target Price
- OMCC N/A
- CRIS $21.00
- AVG Volume (30 Days)
- OMCC 3.2K
- CRIS 54.9K
- Earning Date
- OMCC 02-14-2025
- CRIS 03-31-2025
- Dividend Yield
- OMCC N/A
- CRIS N/A
- EPS Growth
- OMCC N/A
- CRIS N/A
- EPS
- OMCC N/A
- CRIS N/A
- Revenue
- OMCC $25,153,000.00
- CRIS $10,908,000.00
- Revenue This Year
- OMCC N/A
- CRIS N/A
- Revenue Next Year
- OMCC N/A
- CRIS $27.88
- P/E Ratio
- OMCC N/A
- CRIS N/A
- Revenue Growth
- OMCC N/A
- CRIS 8.83
- 52 Week Low
- OMCC $5.29
- CRIS $1.40
- 52 Week High
- OMCC $7.55
- CRIS $17.49
- Technical
- Relative Strength Index (RSI)
- OMCC N/A
- CRIS 15.29
- Support Level
- OMCC N/A
- CRIS $1.40
- Resistance Level
- OMCC N/A
- CRIS $2.62
- Average True Range (ATR)
- OMCC 0.00
- CRIS 0.27
- MACD
- OMCC 0.00
- CRIS -0.11
- Stochastic Oscillator
- OMCC 0.00
- CRIS 4.49
Stock Price Comparison Chart: OMCC vs CRIS
About OMCC OLD MARKET CAPITAL CORPORATION
Old Market Capital Corp formerly Nicholas Financial Inc is a specialized consumer finance company. It is engaged in acquiring and servicing automobile finance installment contracts for purchases of used and new automobiles and light trucks. It also originates direct consumer loans and sells consumer-finance-related products. The majority of its revenue comes from Interest and fee income.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.